| |
 |
|
Class Information
Number: 424/145.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tpa, etc.), or fibrin
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a hormone or with any other secreted growth regulatory factor, differentiation factor, or intercellular mediator; or involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a serum protein, a plasma protein, or with fibrin.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615213 |
Antibodies against human interleukin-13 and pharmaceutical compositions thereof |
Nov. 10, 2009 |
| 7612183 |
Humanised anti-mag antibody or functional fragment thereof |
Nov. 3, 2009 |
| 7608262 |
Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
Oct. 27, 2009 |
| 7608694 |
Antibody molecules having specificity for human IL-1.beta. |
Oct. 27, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7601815 |
Anti-CCL27 antibodies |
Oct. 13, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7597892 |
Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15) |
Oct. 6, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7588761 |
Human antibodies that bind human TNF.alpha. |
Sep. 15, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7585500 |
Fully human monoclonal antibodies to IL-13 |
Sep. 8, 2009 |
| 7585502 |
Mammalian CX.sub.3C chemokine antibodies |
Sep. 8, 2009 |
| 7582296 |
Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
Sep. 1, 2009 |
| 7579001 |
Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
Aug. 25, 2009 |
| 7579000 |
Tissue factor targeted antibodies as anticoagulants |
Aug. 25, 2009 |
| 7575745 |
Ligand for herpes simplex virus entry mediator and methods of use |
Aug. 18, 2009 |
| 7575747 |
A.beta. binding molecules |
Aug. 18, 2009 |
| 7572589 |
Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
Aug. 11, 2009 |
| 7572447 |
Methods and compositions for selective modulation of vascularization |
Aug. 11, 2009 |
| 7569364 |
Anti-NGF antibodies and methods using same |
Aug. 4, 2009 |
| 7566453 |
Methods for treating melanomas |
Jul. 28, 2009 |
| 7560533 |
Binding compounds specific for cysteine-rich soluble protein C23 |
Jul. 14, 2009 |
| 7553488 |
Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions |
Jun. 30, 2009 |
| 7544327 |
Biosensor and method for bone mineral density measurement |
Jun. 9, 2009 |
| 7544357 |
Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
Jun. 9, 2009 |
| 7544782 |
Tumour necrosis factor binding ligands |
Jun. 9, 2009 |
| 7541031 |
Methods for treating rheumatoid arthritis using human antibodies that bind human TNF.alpha. |
Jun. 2, 2009 |
| 7541033 |
Humanized anti-IL-1.beta. antibodies |
Jun. 2, 2009 |
| 7537757 |
Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II |
May. 26, 2009 |
| 7534430 |
Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
May. 19, 2009 |
| 7534431 |
Methods and compositions for administering therapeutic and diagnostic agents |
May. 19, 2009 |
| 7534432 |
Methods of treating musculodegenerative disease with an antibody that binds growth differentiation factor-8 |
May. 19, 2009 |
| 7531169 |
High affinity anti-human IgE antibodies |
May. 12, 2009 |
| 7527790 |
Methods of reducing bone absorption comprising administering an antibody that binds OBM |
May. 5, 2009 |
| 7527791 |
Humanized anti-TGF-beta antibodies |
May. 5, 2009 |
| 7528237 |
Tumour necrosis factor binding ligands |
May. 5, 2009 |
| 7524501 |
Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
Apr. 28, 2009 |
| 7521050 |
Human antibodies that bind human TNF.alpha. |
Apr. 21, 2009 |
| 7521056 |
Stably tethered structures of defined compositions with multiple functions or binding specificities |
Apr. 21, 2009 |
| 7517963 |
Tumour necrosis factor binding ligands |
Apr. 14, 2009 |
| 7517524 |
Immunointeractive molecules |
Apr. 14, 2009 |
| 7517523 |
Anti-MIF antibodies |
Apr. 14, 2009 |
| 7517965 |
Non-neutralizing anti-aPC antibodies |
Apr. 14, 2009 |
| 7514079 |
Antibodies that specifically bind to neurokinin B |
Apr. 7, 2009 |
| 7514077 |
Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists |
Apr. 7, 2009 |
| 7514539 |
Epitope directed selection of antibodies to murine tissue factor |
Apr. 7, 2009 |
| 7510709 |
Method of treating inflammatory disease by inhibition of IL-17 production |
Mar. 31, 2009 |
| 7510830 |
Cancer treatment by combination therapy |
Mar. 31, 2009 |
| 7504485 |
Human antibodies that bind human IL-12 |
Mar. 17, 2009 |
|
|
|
